NL-OMON33348
Not yet recruiting
Not Applicable
Mapping dopaminergic function using pharmacologic Magnetic Resonance Imaging (phMRI) in healthy subjects and users of amphetamine - MPH-MRI
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- drugsgebruik/verslaving
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 20
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male. Between 18 and 35 years of age. Regular use of amphetamines (on more than 40 occasions the past year) for the amphetamine using group
Exclusion Criteria
- •Serious general medical condition or one that could interfere in the interpretation of results
- •\-use of (DA) medication within the last 2 weeks
- •\-excessive consumption of alcohol (\>21 units/ week), caffeine (greater than eight cups of coffee per day) or cigarettes (greater than ten cigarettes per day).
- •\-Contraindications for MRI (e.g. osteosynthetic material, pacemaker, artificial cardiac valves), claustrophobia
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Mapping dopaminergic function using pharmacologic Magnetic Resonance Imaging (phMRI)kinder en jeugd psychiatrienot applicableNL-OMON33010Academisch Medisch Centrum10
Completed
Not Applicable
Mapping dopaminergic function using phMRI in healthy volunteers and amphetamine userskinder en jeugd psychatrieaddictionSubstance dependenceNL-OMON37495Academisch Medisch Centrum40
Completed
Not Applicable
Examination of dopaminergic system using neurofeedback techniqueHealthy individualsJPRN-UMIN000020566ational Institute of Radiological Sciences16
Not yet recruiting
Not Applicable
Investigation of modulation for dopaminergic neuronal system by transcranial direct current stimulation (tDCS)health male adultsJPRN-UMIN000020532ational Institute of Radiological Sciences16
Completed
Not Applicable
The dopaminergic system in patients with functional dyspepsia analyzed by an alpha-methyl-para-tyrosine (AMPT) challenge test and single photon emission computed tomography (SPECT) imaging before and after treatment with amitriptylineFunctional dyspepsia (FD)Digestive SystemDyspepsiaISRCTN63226989Academic Medical Center (AMC), Department of Gastroenterology (The Netherlands)60